Proteasome Inhibitors (PI), Cyclophosphamide+Velcade+Dexamethasone (CVd), 1 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Phase 2, Carfilzomib+Cyclophosphamide+Dexamethasone (KCd)
### Instruction:
Identify the study with the following condition. 
### Input:
Proteasome Inhibitors (PI), Cyclophosphamide+Velcade+Dexamethasone (CVd), 1 prior line of therapy, Relapsed Refractory Multiple Myeloma (RRMM), Phase 2, Carfilzomib+Cyclophosphamide+Dexamethasone (KCd) 
### Output:
Popular Name is MUK Five, Study ID is ISRCTN17354232